Yvonne Naegelin
Overview
Explore the profile of Yvonne Naegelin including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
73
Citations
2323
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Cerda-Fuertes N, Stoessel M, Mickeliunas G, Pless S, Cagol A, Barakovic M, et al.
Mult Scler
. 2023 Sep;
29(13):1540-1550.
PMID: 37772490
Background: Optical coherence tomography (OCT) is a biomarker of neuroaxonal loss in multiple sclerosis (MS). Objective: The objective was to assess the relative role of OCT, next to magnetic resonance...
2.
Woelfle T, Bourguignon L, Lorscheider J, Kappos L, Naegelin Y, Jutzeler C
J Med Internet Res
. 2023 Jul;
25:e44428.
PMID: 37498655
Background: Wearable sensor technologies have the potential to improve monitoring in people with multiple sclerosis (MS) and inform timely disease management decisions. Evidence of the utility of wearable sensor technologies...
3.
Pless S, Woelfle T, Naegelin Y, Lorscheider J, Wiencierz A, Reyes O, et al.
J Neurol
. 2023 Mar;
270(7):3451-3463.
PMID: 36952010
Background: Cognitive impairment occurs in up to 70% of people with MS (pwMS) and has a large impact on quality of life and working capacity. As part of the development...
4.
Cagol A, Fuertes N, Stoessel M, Barakovic M, Schaedelin S, DSouza M, et al.
J Neurol
. 2023 Jan;
270(4):2139-2148.
PMID: 36625888
Background: Retinal degeneration leading to optical coherence tomography (OCT) changes is frequent in patients with multiple sclerosis (PwMS). Objective: To investigate associations among OCT changes, MRI measurements of global and...
5.
Woelfle T, Pless S, Reyes O, Wiencierz A, Feinstein A, Calabrese P, et al.
J Neurol
. 2022 Aug;
270(1):262-271.
PMID: 36042020
Background: There is an unmet need for reliable and sensitive measures for better monitoring people with multiple sclerosis (PwMS) to detect disease progression early and adapt therapeutic measures accordingly. Objective:...
6.
Sinnecker T, Schadelin S, Benkert P, Ruberte E, Amann M, Lieb J, et al.
Neuroimage Clin
. 2022 Aug;
36:103148.
PMID: 36007437
Background: A change in MRI hardware impacts brain volume measurements. The aim of this study was to use MRI data from multiple sclerosis (MS) patients and healthy control subjects (HCs)...
7.
Tsagkas C, Geiter E, Gaetano L, Naegelin Y, Amann M, Parmar K, et al.
Neuroimage Clin
. 2022 Aug;
35:103137.
PMID: 36002960
Objective: This study aimed to investigate longitudinal deep gray matter (DGM) shape changes and their relationship with measures of clinical disability and white matter lesion-load in a large multiple sclerosis...
8.
Zandl-Lang M, Zullig T, Trotzmuller M, Naegelin Y, Abela L, Wilken B, et al.
Metabolites
. 2022 Apr;
12(4).
PMID: 35448478
Rett syndrome (RTT) is defined as a rare disease caused by mutations of the methyl-CpG binding protein 2 (MECP2). It is one of the most common causes of genetic mental...
9.
Benkert P, Meier S, Schaedelin S, Manouchehrinia A, Yaldizli O, Maceski A, et al.
Lancet Neurol
. 2022 Feb;
21(3):246-257.
PMID: 35182510
Background: Serum neurofilament light chain (sNfL) is a biomarker of neuronal damage that is used not only to monitor disease activity and response to drugs and to prognosticate disease course...
10.
Woelfle T, Pless S, Wiencierz A, Kappos L, Naegelin Y, Lorscheider J
J Med Internet Res
. 2021 Nov;
23(11):e30394.
PMID: 34792480
Background: Smartphones and their built-in sensors allow for measuring functions in disease-related domains through mobile tests. This could improve disease characterization and monitoring, and could potentially support treatment decisions for...